1 Université de Paris, Innovative Therapies in Hemostasis, INSERM, Paris, France david.smadja@aphp.fr.
2 Hematology Dept and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
3 F-CRIN INNOVTE Network, Saint Etienne, France.
4 Uppsala Monitoring Centre, Uppsala, Sweden.
5 Emergency Dept, Université de Paris, PARCC, INSERM U970, AP-HP-Centre Université de Paris (APHP-CUP), Paris, France.
6 Université de Paris, Innovative Therapies in Hemostasis, INSERM, Paris, France.
7 Respiratory Medicine Dept and Biosurgical Research Lab (Carpentier Foundation), Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
8 Pharmacovigilance Dept, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Paris, France.
This study observed an imbalance between venous and arterial thrombotic events in mRNA vaccines while with AZ1222 they are evenly shared. Our analysis highlights cerebral vein thrombosis with the three vaccines.https://bit.ly/3mZqguE